Osteoporosis is a skeletal disorder that causes impairment of bone structure and strength,
leading to a progressively increased risk of fragility fractures. The global prevalence of …

Osteoporosis is a systemic skeletal disease characterized by low bone mass and
microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility …

A 70 year old white woman presented to her general practitioner for her annual check-up.
She weighs 62 kg and is 164 cm tall. She is a tobacco user (20 pack-year) with prior wrist …

Objective: This study aims to explore the risk signals of osteonecrosis of the jaw induced by
antiresorptive drugs and provide references for the clinical safety application. Method …

Oral bisphosphonates are a key intervention in the treatment of osteoporosis and in
reducing the risk of fragility fractures. Their use is supported by over 3 decades of evidence; …

In the treatment and prevention of osteoporosis and more generally of neoplastic and
metabolic pathologies affecting bone tissues, antiresorption drugs such as bisphosphonates …

We investigated the incidence/trend of osteonecrosis of the jaw by antiresorptive agent dose
over a 5-year period in Kure city, Japan. The incidence was 24 times higher among …

Medication-related osteonecrosis of the jaw (MRONJ) is a major complication of
bisphosphonate treatment in cancer patients, and its etiology is not completely clarified. The …

Increased life expectancy means that women are now in a hypoestrogenic state for
approximately one-third of their lives. Overall health and specifically bone health during this …

RIASSUNTO OBIETTIVI Questo joint report della SIPMO e della SIOMMMS mira a definire la
gestione odontoiatrica dei pazienti con cancro al seno o alla prostata in terapia con farmaci …